Enfermedades infecciosas y microbiologia clinica最新文献_第2页

Violaceous plaque in an immunosuppressed patient's leg

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-04-01 DOI: 10.1016/j.eimc.2024.07.009

Rodolfo David Palacios-Diaz , Iván Rienda-Martínez , Antonio Sahuquillo-Torralba , Rafael Botella-Estrada

引用次数: 0

Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in the Northwestern region of Spain, 2019–2022

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-04-01 DOI: 10.1016/j.eimc.2024.10.006

Antonio Moreno-Flores , María Domínguez-Landesa , Laura Sante-Fernández , María José Gude-González

引用次数: 0

Experiencia en Canarias de una estrategia de cribado de VIH en los servicios de urgencias hospitalarios: resultados del programa «Deja tu huella»

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-04-01 DOI: 10.1016/j.eimc.2024.12.020

Nayra Cabrera-González , José M. Pavón-Monzó , Araceli Hernández-Betancor , Isidro Báez-Ramos

引用次数: 0

Eficacia del tratamiento con benznidazol en la enfermedad de Chagas crónica digestiva avanzada

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-04-01 DOI: 10.1016/j.eimc.2024.12.014

Marta Díaz-Menéndez, Rosa de Miguel Buckley, Fernando de la Calle-Prieto, Marta Arsuaga

引用次数: 0

Dermatofitosis causadas por Nannizzia gypsea: informe de 155 casos en el oeste de México

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-04-01 DOI: 10.1016/j.eimc.2024.08.011

Enrique Adolfo Orozco-Yee , Raquel Guadalupe Rojas-Castañeda , Elizabeth Guevara-Gutiérrez , Jorge Mayorga-Rodríguez , Alberto Tlacuilo-Parra

{"title":"Dermatofitosis causadas por Nannizzia gypsea: informe de 155 casos en el oeste de México","authors":"Enrique Adolfo Orozco-Yee , Raquel Guadalupe Rojas-Castañeda , Elizabeth Guevara-Gutiérrez , Jorge Mayorga-Rodríguez , Alberto Tlacuilo-Parra","doi":"10.1016/j.eimc.2024.08.011","DOIUrl":"10.1016/j.eimc.2024.08.011","url":null,"abstract":"<div><h3>Background</h3><div>Dermatophytosis caused by <em>Nannizzia gypsea</em> are considered rare. The clinical picture is indistinguishable from that produced by other dermatophytes, but, being this a geophilic fungus, it can cause more inflammatory disease.</div></div><div><h3>Methods</h3><div>Retrospective study. Patients with positive culture for <em>N.</em> <em>gypsea</em> observed at the Dermatological Institute of Jalisco «Dr. José Barba Rubio», from 2001 to 2023, were included. Frequency, sex, age, evolution, and clinical variant were investigated. We compared the findings between the pediatric versus adult population. Descriptive and inferential statistics were used.</div></div><div><h3>Results</h3><div>Over 23 years, 155 patients were diagnosed (6.7 cases per year). Female sex predominated (53.5%). The median age was 9years (minimum 1year and maximum 85years), the more affected age group was 1 to 10years (54.2%). The median time of evolution was 30days (minimum one day and maximum 3years), and 74.8% had an evolution ≤30days. Tinea capitis predominated in pediatric patients (41.0%, <em>P</em>  <.01). Inflammatory tinea was more prevalent in the pediatric population (21.0% <em>vs</em>. 3.6%, <em>P</em>  <!-->.01).</div></div><div><h3>Conclusion</h3><div>The ability of <em>N.</em> <em>gypsea</em> to cause inflammatory tinea was observed primarily in pediatric patients. Since there is no clinical data to suspect this fungus, it will always be necessary to carry out a mycological study to identify the species and to implement the appropriate treatment.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 4","pages":"Pages 205-209"},"PeriodicalIF":2.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143748575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Lung cancer screening in people with HIV: A missed opportunity for better outcomes? 艾滋病病毒感染者的肺癌筛查：错失改善疗效的良机？

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-03-01 DOI: 10.1016/j.eimc.2024.12.005

Mar Masiá , Félix Gutiérrez

引用次数: 0

Uncommon lip lesions in an HIV individual 艾滋病毒感染者罕见的唇部病变

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-03-01 DOI: 10.1016/j.eimc.2024.06.017

Diego Ulises Vázquez Omaña , Roxana Claudia Iquize Condori , Ariel García Torralba , Miguel Ángel Martínez Rojas , Pamela Monserrat Vidales Higuera , Alvaro López Iñiguez

引用次数: 0

Endocarditis infecciosa por Achromobacter xylosoxidans después de implante de válvula aórtica percutánea: a propósito de un caso

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-03-01 DOI: 10.1016/j.eimc.2024.11.004

Amparo Buforn Pascual , José Albors Martín , Coral Llopis Ruiz , Adriana Hernández Belmonte

引用次数: 0

Programa de profilaxis pre-exposición de la Comunidad de Madrid: 2 años de experiencia 马德里社区的接触前预防计划：两年的经验。

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-03-01 DOI: 10.1016/j.eimc.2024.03.014

Nuria Fernández Piñeiro , Oskar Ayerdi Aguirrebengoa , Eva Orviz García , Cristina González Pérez , Mar Vera García , Teresa Puerta López , Carmen Rodríguez Martín , Clara Lejarraga Cañas , Jorge Perez García , Begoña Baza Caraciolo , Monserrat González Polo , Florentina Alcudia Pérez , Marta Ruiz Fernández , Natividad Jerez Zamora , Diego Morales Irala , Beatriz López Centeno , Daniele Alioto , José Manuel Martínez Sesmero , Vicente Estrada Pérez , María Teresa Benítez Gimenez , Jorge del Romero Guerrero

{"title":"Programa de profilaxis pre-exposición de la Comunidad de Madrid: 2 años de experiencia","authors":"Nuria Fernández Piñeiro , Oskar Ayerdi Aguirrebengoa , Eva Orviz García , Cristina González Pérez , Mar Vera García , Teresa Puerta López , Carmen Rodríguez Martín , Clara Lejarraga Cañas , Jorge Perez García , Begoña Baza Caraciolo , Monserrat González Polo , Florentina Alcudia Pérez , Marta Ruiz Fernández , Natividad Jerez Zamora , Diego Morales Irala , Beatriz López Centeno , Daniele Alioto , José Manuel Martínez Sesmero , Vicente Estrada Pérez , María Teresa Benítez Gimenez , Jorge del Romero Guerrero","doi":"10.1016/j.eimc.2024.03.014","DOIUrl":"10.1016/j.eimc.2024.03.014","url":null,"abstract":"<div><h3>Introduction</h3><div>Pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) is an effective and safe preventive measure. However, it has not reached all target users who could benefit from it.</div><div>The study aimed to understand the sociodemographic, clinical and behavioral baseline characteristics of PrEP users. As a secondary objective, the use of concomitant medication and drug consumption were described.</div></div><div><h3>Methodology</h3><div>Observational, retrospective and descriptive study of the sociodemographic, clinical and behavioral characteristics of the users who were included in the PrEP program of the Community of Madrid during the first two years of experience.</div></div><div><h3>Results</h3><div>Two thousand two hundred fifty-six PrEP users were included, 99.0% men, with a mean age of 36.9 years (SD: 8.68). 33.1% presented a sexually transmitted infection (STI) on the first visit, highlighting chlamydiasis and rectal gonococci. 70.4% reported using drugs associated with sex, and 42.4% participated in chemsex sessions in the last 3 months. A high percentage of users with concomitant medication was observed (37.6%), highlighting drugs related to mental health and alopecia.</div></div><div><h3>Conclusions</h3><div>A multidisciplinary approach is required to cover all the needs of PrEP users, including mental health evaluation measures and addiction treatment with the clinical approach.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 133-138"},"PeriodicalIF":2.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141058361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence and antimicrobial susceptibility profile of Corynebacterium glucuronolyticum in genitourinary tract samples

IF 2.6 4区医学

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-03-01 DOI: 10.1016/j.eimc.2024.10.007

Ana Cotos Suárez, Fernando García-Garrote, Laura Sancha Domínguez, Ana María Blázquez de Castro, María del Mar Collado Llano, Eva María Lorenzo Iglesias

{"title":"Prevalence and antimicrobial susceptibility profile of Corynebacterium glucuronolyticum in genitourinary tract samples","authors":"Ana Cotos Suárez, Fernando García-Garrote, Laura Sancha Domínguez, Ana María Blázquez de Castro, María del Mar Collado Llano, Eva María Lorenzo Iglesias","doi":"10.1016/j.eimc.2024.10.007","DOIUrl":"10.1016/j.eimc.2024.10.007","url":null,"abstract":"<div><h3>Introduction</h3><div><em>Corynebacterium glucuronolyticum</em> (<em>C. glucuronolyticum</em>) is a species recently recognized as a potential pathogen of the male genitourinary tract. The objective is to determine the prevalence of <em>C. glucuronolyticum</em> in genitourinary tract samples as well as their antimicrobial susceptibility profile.</div></div><div><h3>Methods</h3><div>A prospective study was conducted from 1st of November 2021 to the 30th of November 2022, for all genitourinary tract samples collected from male patients with suspicion of balanitis, prostatitis and urethritis. Antimicrobial susceptibility testing was performed in all <em>C. glucuronolyticum</em> isolates.</div></div><div><h3>Results</h3><div>A total of 73 <em>C. glucuronolyticum</em> isolates from 693 clinical specimens were obtained. This represents an overall <em>C. glucuronolyticum</em> prevalence of 10.5%. All strains were susceptible to vancomycin, linezolid and rifampicin, whereas 94%, 68% and 65% were resistant to clindamycin, tetracycline and ciprofloxacin, respectively.</div></div><div><h3>Conclusion</h3><div>Clinical microbiology laboratories should perform antimicrobial susceptibility testing against <em>C. glucuronolyticum</em> due to the significant rate of resistance to ciprofloxacin and tetracycline.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 162-164"},"PeriodicalIF":2.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143527087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0